---
run_id: halo-evidence-vs-diagnosis-validation-v10-vanilla-long-prompt-02
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v10
benchmark_version: halo-evidence-vs-diagnosis-validation-v10-v1
model_condition: vanilla_long_prompt
run_number: 2
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 204
prompt_source: condition packet (vanilla_long_prompt) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: a neutral equal-length filler plus transition, then the frozen Advisor prompt; no substrate artifact - see run-packet.md
source_packet_sha256: 725394e5c302c1e30265374a9742db053b2cd62aaaaf76c7381b6fcdd8c7558b
condition_packet_sha256: 725394e5c302c1e30265374a9742db053b2cd62aaaaf76c7381b6fcdd8c7558b
output_file: model-outputs/vanilla_long_prompt-02.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla_long_prompt (run 02)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v10-v1`, condition `vanilla_long_prompt`, run 2 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 204, on the frozen condition packet.

## Output

**Recommendation:** Run the **Claim File Review**.

**Why:** Your current growth signals are "entangled" and likely artificial. Expansion bookings are driven by temporary pricing bundles rather than perceived value, and usage spikes are being skewed by managers running samples for meetings rather than adjusters using the tool for production. Most critically, you have a "black box" problem: health-liability adjusters are abandoning the tool because they cannot explain its logic to reviewers.

The Usage Quality Sprint tracks *that* people are using the tool, and the Commercial Cleanroom tracks *if* they will pay for it, but neither explains *why* the product is failing in production. The Claim File Review is the only option that provides a qualitative autopsy of the workflow (accepted vs. overridden vs. impossible to explain). This evidence is required to determine if DraftPath needs a fundamental architectural change (explainability) or simply better enablement before you commit next year's budget to scaling a leaky bucket.

**Strongest Reason Against:** This is the slowest and most labor-intensive of the three validation tests. It requires manual effort from adjusters and reviewers, providing a small sample size of deep insight rather than the broad, quantitative data provided by the Usage Quality Sprint or the Commercial Cleanroom.

**Evidence That Would Change My Mind:** If the "wrong recommendation" support tickets (now hidden in training channels) showed a drastic decrease in actual error rates and an increase in "how-to" queries, I would shift to the **Commercial Cleanroom**. This would suggest the product is functionally sound and the primary risk is merely a pricing/packaging misalignment rather than a core utility failure.
